DNA
Ginkgo Bioworks Holdings
11.50$
-7.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 13.3% | 43.2% | 53.7% | 39.2% | 28.7% | 44.8% | 50.7% | 44.2% | 37.1% | 30.7% | 27.7% | 22.5% | 12.5% | 19.0% | 24.3% | 24.4% | 11.2% | 21.9% | 24.9% | 29.9% | 33.0% | -24.4% | 81.6% | 8.5% | 19.9% | |
| 100.0% | 100.0% | 86.7% | 56.8% | 46.3% | 60.8% | 71.3% | 55.2% | 49.3% | 55.8% | 62.9% | 69.3% | 72.3% | 77.5% | 87.5% | 81.0% | 75.7% | 75.6% | 88.8% | 78.1% | 75.1% | 70.1% | 67.0% | 124.4% | 18.4% | 91.5% | 80.1% | |
| 143.1% | 317.5% | 271.2% | 190.9% | 135.1% | 119.2% | 68.3% | 663.3% | 192.1% | 200.6% | 393.8% | 184.3% | 201.5% | 179.1% | 282.6% | 336.8% | 359.6% | 238.8% | 86.5% | 174.2% | 146.8% | 107.6% | 178.6% | 150.1% | 256.3% | 229.3% | 192.7% | |
| 31.1% | 88.1% | 74.2% | 40.3% | 40.7% | 78.9% | 37.3% | 526.4% | 258.2% | 303.2% | 655.5% | 123.5% | 138.1% | 127.0% | 148.0% | 256.7% | 185.2% | 117.9% | 58.7% | 130.7% | 101.5% | 87.2% | 115.8% | 137.8% | 194.3% | 152.7% | 142.7% | |
| 174.1% | 405.6% | 345.4% | 231.2% | 175.8% | 198.2% | 105.6% | 1,189.7% | 450.3% | 503.7% | 1,049.2% | 307.9% | 339.6% | 306.1% | 604.2% | 593.5% | 544.9% | 472.2% | 150.8% | 314.3% | 259.2% | 202.2% | 298.8% | 336.3% | 384.9% | 381.9% | 340.0% | |
| -74.1% | -305.6% | -258.7% | -174.3% | -129.5% | -137.4% | -34.4% | -1,134.5% | -401.0% | -447.9% | -986.4% | -238.6% | -267.3% | -228.6% | -516.7% | -512.5% | -469.1% | -396.7% | -62.0% | -236.3% | -184.1% | -132.1% | -231.8% | -211.9% | -366.5% | -290.5% | -259.9% | |
| – | – | 4.5% | 1.8% | 1.1% | 1.1% | 0.8% | 0.4% | 0.2% | 1.2% | 2.5% | 13.3% | 7.1% | – | – | 0.3% | – | – | – | 0.2% | – | – | – | – | – | – | – | |
| -111.7% | -282.6% | -196.4% | -144.7% | -169.9% | -125.8% | -132.2% | -1,081.3% | -352.0% | -463.7% | -1,009.3% | -192.2% | -253.9% | -215.0% | -546.5% | -609.7% | -437.2% | -386.1% | -63.8% | -246.0% | -188.1% | -122.1% | -207.9% | -243.7% | -391.0% | -283.8% | -264.1% | |
| 8.8% | 0.1% | 0.0% | 0.0% | -0.4% | -1.0% | -0.3% | -0.5% | -0.1% | 0.0% | 0.0% | -15.0% | 0.1% | 0.1% | 0.0% | -0.6% | 0.1% | 0.3% | -0.4% | -0.7% | 0.2% | -0.6% | 0.0% | -1.9% | -0.4% | 0.6% | -0.5% | |
| -118.2% | -282.0% | -195.9% | -146.4% | -166.8% | -123.6% | -131.3% | -1,077.9% | -350.6% | -462.5% | -1,009.3% | -179.6% | -254.0% | -215.1% | -546.4% | -609.1% | -437.3% | -386.4% | -63.3% | -245.2% | -188.2% | -121.6% | -207.9% | -241.8% | -424.1% | -231.7% | -260.0% | |
| -59.2% | -274.3% | -165.4% | -161.8% | -156.1% | -108.3% | -120.7% | -1,075.5% | -346.5% | -456.8% | -997.4% | -133.3% | -230.4% | -193.1% | -305.1% | -831.2% | -403.3% | -250.3% | -39.4% | -327.2% | -141.4% | -92.9% | -171.4% | -104.4% | -325.3% | -220.1% | -187.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.